Unity Biotechnology (NASDAQ:UBX – Get Free Report) had its price objective cut by research analysts at Chardan Capital from $6.00 to $4.00 in a research report issued on Tuesday,Benzinga reports. The ...
CACI International (NYSE:CACI – Get Free Report) had its price target cut by investment analysts at Jefferies Financial Group from $520.00 to $455.00 in a research report issued on Tuesday, Marketbeat ...